% alzhub.org library filter % Source: https://alzhub.org/research?institution=I136199984&atag=randomized % 38 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{zimmer2025-40063015, author = {Zimmer, J. A. and Ardayfio, P. and Wang, H. and Khanna, R. and Evans, C. D. and Lu, M. and Sparks, J. and Andersen, S. and Lauzon, S. and Nery, E. S. M. and others}, title = {{Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials}}, journal = {JAMA Neurology}, year = {2025}, doi = {10.1001/jamaneurol.2025.0065}, pmid = {40063015}, url = {https://doi.org/10.1001/jamaneurol.2025.0065} } @article{florian2023-36730056, author = {Florian, H. and Wang, D. and Arnold, S. E. and Boada, M. and Guo, Q. and Jin, Z. and Zheng, H. and Fisseha, N. and others}, title = {{Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study}}, journal = {Brain : a journal of neurology}, year = {2023}, doi = {10.1093/brain/awad024}, pmid = {36730056}, url = {https://doi.org/10.1093/brain/awad024} } @article{ostrowitzki2022-36121669, author = {Ostrowitzki, S. and Bittner, T. and Sink, K. M. and Mackey, H. and Rabe, C. and Honig, L. S. and Cassetta, E. and Woodward, M. and others}, title = {{Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.2909}, pmid = {36121669}, url = {https://doi.org/10.1001/jamaneurol.2022.2909} } @article{cummings2025-39780249, author = {Cummings, J. L. and Atri, A. and Feldman, H. H. and Hansson, O. and Sano, M. and Knop, F. K. and Johannsen, P. and León, T. and others}, title = {{evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2025}, doi = {10.1186/s13195-024-01666-7}, pmid = {39780249}, url = {https://doi.org/10.1186/s13195-024-01666-7} } @article{honig2024-38730496, author = {Honig, L. S. and Sabbagh, M. N. and van Dyck, C. H. and Sperling, R. A. and Hersch, S. and Matta, A. and Giorgi, L. and Gee, M. and others}, title = {{Updated safety results from phase 3 lecanemab study in early Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2024}, doi = {10.1186/s13195-024-01441-8}, pmid = {38730496}, url = {https://doi.org/10.1186/s13195-024-01441-8} } @article{atri2018-29318278, author = {Atri, A. and Frölich, L. and Ballard, C. and Tariot, P. N. and Molinuevo, J. L. and Boneva, N. and Windfeld, K. and Raket, L. L. and others}, title = {{Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials}}, journal = {JAMA}, year = {2018}, doi = {10.1001/jama.2017.20373}, pmid = {29318278}, url = {https://doi.org/10.1001/jama.2017.20373} } @article{sabbagh2020-31879235, author = {Sabbagh, M. and Sadowsky, C. and Tousi, B. and Agronin, M. E. and Alva, G. and Armon, C. and Bernick, C. and Keegan, A. P. and others}, title = {{Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2020}, doi = {10.1016/j.jalz.2019.08.197}, pmid = {31879235}, url = {https://doi.org/10.1016/j.jalz.2019.08.197} } @article{wang2025-40172303, author = {Wang, H. and Serap Monkul Nery, E. and Ardayfio, P. and Khanna, R. and Otero Svaldi, D. and Gueorguieva, I. and Shcherbinin, S. and Andersen, S. W. and Hauck, P. M. and Engle, S. E. and others}, title = {{Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction}}, journal = {Alzheimer's \& Dementia}, year = {2025}, doi = {10.1002/alz.70062}, pmid = {40172303}, url = {https://doi.org/10.1002/alz.70062} } @article{wagemann2024-38683602, author = {Wagemann, O. and Liu, H. and Wang, G. and Shi, X. and Bittner, T. and Scelsi, M. A. and Farlow, M. R. and Clifford, D. B. and others}, title = {{Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2024}, doi = {10.1001/jamaneurol.2024.0991}, pmid = {38683602}, url = {https://doi.org/10.1001/jamaneurol.2024.0991} } @article{bodick1997-9109749, author = {Bodick, N. C. and Offen, W. W. and Levey, A. I. and Cutler, N. R. and Gauthier, S. G. and Satlin, A. and Shannon, H. E. and Tollefson, G. D. and others}, title = {{Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease}}, journal = {Archives of neurology}, year = {1997}, doi = {10.1001/archneur.1997.00550160091022}, pmid = {9109749}, url = {https://doi.org/10.1001/archneur.1997.00550160091022} } @article{chew2015-26305649, author = {Chew, E. Y. and Clemons, T. E. and Agrón, E. and Launer, L. J. and Grodstein, F. and Bernstein, P. S.}, title = {{Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial}}, journal = {JAMA}, year = {2015}, doi = {10.1001/jama.2015.9677}, pmid = {26305649}, url = {https://doi.org/10.1001/jama.2015.9677} } @article{shinto2024-39088212, author = {Shinto, L. H. and Murchison, C. F. and Silbert, L. C. and Dodge, H. H. and Lahna, D. and Rooney, W. and Kaye, J. and Quinn, J. F. and others}, title = {{ω-3 PUFA for Secondary Prevention of White Matter Lesions and Neuronal Integrity Breakdown in Older Adults: A Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2024}, doi = {10.1001/jamanetworkopen.2024.26872}, pmid = {39088212}, url = {https://doi.org/10.1001/jamanetworkopen.2024.26872} } @article{ko2022-36399339, author = {Ko, Darae and Lin, Kueiyu Joshua and Bessette, Lily Gui and Lee, Su Been and Walkey, Allan J. and Cheng, Susan C. and Kim, Erin and Glynn, Robert J. and others}, title = {{Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020}}, journal = {JAMA Network Open}, year = {2022}, doi = {10.1001/jamanetworkopen.2022.42964}, pmid = {36399339}, url = {https://doi.org/10.1001/jamanetworkopen.2022.42964} } @article{liu2018-29429971, author = {Liu, E. and Wang, D. and Sperling, R. and Salloway, S. and Fox, N. C. and Blennow, K. and Scheltens, P. and Schmidt, M. E. and others}, title = {{Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab}}, journal = {Neurology}, year = {2018}, doi = {10.1212/wnl.0000000000005060}, pmid = {29429971}, url = {https://doi.org/10.1212/wnl.0000000000005060} } @article{shao2012-23100399, author = {Shao, H. and Breitner, J. C. and Whitmer, R. A. and Wang, J. and Hayden, K. and Wengreen, H. and Corcoran, C. and Tschanz, J. and others}, title = {{Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study}}, journal = {Neurology}, year = {2012}, doi = {10.1212/wnl.0b013e318271f823}, pmid = {23100399}, url = {https://doi.org/10.1212/wnl.0b013e318271f823} } @article{wetmore2024-39748836, author = {Wetmore, J. B. and Rodriguez, S. and Diaz Caro, D. and Cabán, M. and Uhlmann, W. and Goldman, J. and Leu, C. S. and Godinez, J. D. and others}, title = {{Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late-onset Alzheimer's disease in an urban Latino population}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2024}, doi = {10.1002/trc2.70016}, pmid = {39748836}, url = {https://doi.org/10.1002/trc2.70016} } @article{vandyck2019-31329216, author = {van Dyck, C. H. and Nygaard, H. B. and Chen, K. and Donohue, M. C. and Raman, R. and Rissman, R. A. and Brewer, J. B. and Koeppe, R. A. and others}, title = {{Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2019}, doi = {10.1001/jamaneurol.2019.2050}, pmid = {31329216}, url = {https://doi.org/10.1001/jamaneurol.2019.2050} } @article{viswanathan2009-19153374, author = {Viswanathan, A. and Raj, S. and Greenberg, S. M. and Stampfer, M. and Campbell, S. and Hyman, B. T. and Irizarry, M. C.}, title = {{Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial}}, journal = {Neurology}, year = {2009}, doi = {10.1212/01.wnl.0000339486.63862.db}, pmid = {19153374}, url = {https://doi.org/10.1212/01.wnl.0000339486.63862.db} } @article{vandyck2025-41355080, author = {van Dyck, C. H. and Sperling, R. and Johnson, K. and Dhadda, S. and Kanekiyo, M. and Li, D. and Gee, M. and Hersch, S. and Irizarry, M. and Kramer, L.}, title = {{Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the Clarity AD open-label extension study}}, journal = {Alzheimer's \& Dementia}, year = {2025}, doi = {10.1002/alz.70905}, pmid = {41355080}, url = {https://doi.org/10.1002/alz.70905} } @article{atri2026-42128444, author = {Atri, A. and Apostolova, L. G. and Iwata, A. and Wessels, A. M. and Atkins, A. and Lu, M. and Ye, W. and Ryan, S. and Doty, E. G.}, title = {{Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial}}, journal = {Neurology: Clinical Practice}, year = {2026}, doi = {10.1212/CPJ.0000000000200621}, pmid = {42128444}, url = {https://doi.org/10.1212/CPJ.0000000000200621} } @article{johnson2013-23375563, author = {Johnson, K. A. and Sperling, R. A. and Gidicsin, C. M. and Carmasin, J. S. and Maye, J. E. and Coleman, R. E. and Reiman, E. M. and Sabbagh, M. N. and others}, title = {{Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2013}, doi = {10.1016/j.jalz.2012.10.007}, pmid = {23375563}, url = {https://doi.org/10.1016/j.jalz.2012.10.007} } @article{roberts2012-22498844, author = {Roberts, J. S. and Chen, C. A. and Uhlmann, W. R. and Green, R. C.}, title = {{Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease}}, journal = {Genetics in medicine : official journal of the American College of Medical Genetics}, year = {2012}, doi = {10.1038/gim.2012.37}, pmid = {22498844}, url = {https://doi.org/10.1038/gim.2012.37} } @article{sano1997-9110909, author = {Sano, Mary and Ernesto, Christopher and Thomas, Ronald G. and Klauber, Melville R. and Schafer, Kimberly A and Grundman, Michael and Woodbury, Peter and Growdon, John H. and Cotman, Carl W. and Pfeiffer, Eric A. and Schneider, Lon S. and Thal, Leon J.}, title = {{A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study}}, journal = {New England Journal of Medicine}, year = {1997}, doi = {10.1056/nejm199704243361704}, pmid = {9110909}, url = {https://doi.org/10.1056/nejm199704243361704} } @article{rosenberg2025-41350162, author = {Rosenberg, P. B. and Amjad, H. and Burhanullah, H. and Nowrangi, M. and Vandrey, R. and Pierre, M. J. and Outen, J. D. and Schultz, M. and Marano, C. and Agronin, M. and others}, title = {{A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease}}, journal = {The American Journal of Geriatric Psychiatry}, year = {2025}, doi = {10.1016/j.jagp.2025.10.011}, pmid = {41350162}, url = {https://doi.org/10.1016/j.jagp.2025.10.011} } @article{woodworth2023-37831492, author = {Woodworth, E. C. and Briskin, E. A. and Plys, E. and Macklin, E. and Tatar, R. G. and Huberty, J. and Vranceanu, A. M.}, title = {{Mindfulness-Based App to Reduce Stress in Caregivers of Persons With Alzheimer Disease and Related Dementias: Protocol for a Single-Blind Feasibility Proof-of-Concept Randomized Controlled Trial}}, journal = {JMIR research protocols}, year = {2023}, doi = {10.2196/50108}, pmid = {37831492}, url = {https://doi.org/10.2196/50108} } @article{black2010-20505438, author = {Black, R. S. and Sperling, R. A. and Safirstein, B. and Motter, R. N. and Pallay, A. and Nichols, A. and Grundman, M.}, title = {{A single ascending dose study of bapineuzumab in patients with Alzheimer disease}}, journal = {Alzheimer disease and associated disorders}, year = {2010}, doi = {10.1097/wad.0b013e3181c53b00}, pmid = {20505438}, url = {https://doi.org/10.1097/wad.0b013e3181c53b00} } @article{koch2025-40176122, author = {Koch, Giacomo and Casula, Elias Paolo and Bonnı̀, Sonia and Borghi, Ilaria and Assogna, Martina and Di Lorenzo, Francesco and Esposito, Romina and Maiella, Michele and others}, title = {{Effects of 52 weeks of precuneus rTMS in Alzheimer’s disease patients: a randomized trial}}, journal = {Alzheimer s Research \& Therapy}, year = {2025}, doi = {10.1186/s13195-025-01709-7}, pmid = {40176122}, url = {https://doi.org/10.1186/s13195-025-01709-7} } @article{sano1996-8876776, author = {Sano, M. and Ernesto, C. and Klauber, M. R. and Schafer, K. and Woodbury, P. and Thomas, R. and Grundman, M. and Growdon, J. and others}, title = {{Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study}}, journal = {Alzheimer disease and associated disorders}, year = {1996}, doi = {10.1097/00002093-199601030-00004}, pmid = {8876776}, url = {https://doi.org/10.1097/00002093-199601030-00004} } @article{doraiswamy2014-24614494, author = {Doraiswamy, P. M. and Sperling, R. A. and Johnson, K. and Reiman, E. M. and Wong, T. Z. and Sabbagh, M. N. and Sadowsky, C. H. and Fleisher, A. S. and others}, title = {{Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study}}, journal = {Molecular psychiatry}, year = {2014}, doi = {10.1038/mp.2014.9}, pmid = {24614494}, url = {https://doi.org/10.1038/mp.2014.9} } @article{ross2022-35344024, author = {Ross, E. L. and Weinberg, M. S. and Arnold, S. E.}, title = {{Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.0315}, pmid = {35344024}, url = {https://doi.org/10.1001/jamaneurol.2022.0315} } @article{njamnshi2025-41395729, author = {Njamnshi, Wepnyu Yembe and Chiotis, Konstantinos and Tsoy, Elena and Blazhenets, Ganna and Maiti, Piyush and Zhang, Jiaxiuxiu and Allen, Isabel Elaine and Rocha, Salma and others}, title = {{Tablet‐based Cognitive Assessment Tool (TabCAT) in a multisite study of early‐onset Alzheimer's disease}}, journal = {Alzheimer s \& Dementia}, year = {2025}, doi = {10.1002/alz.71012}, pmid = {41395729}, url = {https://doi.org/10.1002/alz.71012} } @article{sveikata2022-34905943, author = {Sveikata, L. and Charidimou, A. and Viswanathan, A.}, title = {{Vessels Sing Their ARIAs: The Role of Vascular Amyloid in the Age of Aducanumab}}, journal = {Stroke}, year = {2022}, doi = {10.1161/strokeaha.121.036873}, pmid = {34905943}, url = {https://doi.org/10.1161/strokeaha.121.036873} } @article{saltmarche2017-28186867, author = {Saltmarche, A. E. and Naeser, M. A. and Ho, K. F. and Hamblin, M. R. and Lim, L.}, title = {{Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report}}, journal = {Photomedicine and laser surgery}, year = {2017}, doi = {10.1089/pho.2016.4227}, pmid = {28186867}, url = {https://doi.org/10.1089/pho.2016.4227} } @article{madigan2012-22877803, author = {Madigan, D. and Sigelman, D. W. and Mayer, J. W. and Furberg, C. D. and Avorn, J.}, title = {{Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies}}, journal = {American heart journal}, year = {2012}, doi = {10.1016/j.ahj.2012.05.002}, pmid = {22877803}, url = {https://doi.org/10.1016/j.ahj.2012.05.002} } @article{singhal2025-40359013, author = {Singhal, Tarun and Cicero, Steven and Gale, Seth A. and Horan, Nicolas and Dubey, Shipra and Marshall, Gad A. and Weiner, Howard L.}, title = {{Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer’s Disease Dementia}}, journal = {Clinical Nuclear Medicine}, year = {2025}, doi = {10.1097/rlu.0000000000005955}, pmid = {40359013}, url = {https://doi.org/10.1097/rlu.0000000000005955} } @article{thakurathi2012-22730476, author = {Thakurathi, Neelam and Henderson, David C.}, title = {{Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorder}}, journal = {Evidence-Based Mental Health}, year = {2012}, doi = {10.1136/ebmental-2012-100740}, pmid = {22730476}, url = {https://doi.org/10.1136/ebmental-2012-100740} } @article{stern2025-41435407, author = {Stern, Andrew M. and Francis, Anna G. and Meunier, Angela L. and Anderson, Amirah K. and Hennessey, Elizabeth L. and Miller, Michael B. and Lemere, Cynthia Ann and Selkoe, Dennis J.}, title = {{Lecanemab, aducanumab, and donanemab bind the same human Alzheimer disease Aβ aggregates at different epitopes}}, journal = {Alzheimer s \& Dementia}, year = {2025}, doi = {10.1002/alz70855_099914}, pmid = {41435407}, url = {https://doi.org/10.1002/alz70855_099914} } @article{lopezlarraz2026-5e962d7a, author = {Lopez-Larraz, E. and Oriol, D. and Fierro, G. and Jubera-Garcia, E. and Klinzing, J. G. and Sierra-Torralba, M. and Horna-Prat, E. and Escolano and others}, title = {{One night of closed-loop auditory stimulation during sleep enhances memory consolidation in patients with Alzheimer's Disease}}, journal = {medRxiv (preprint)}, year = {2026}, doi = {10.64898/2026.09.14.26360893}, url = {https://doi.org/10.64898/2026.09.14.26360893} }